Recruiting
Phase 2

DONQ52

Sponsor:

Chugai Pharmaceutical

Code:

NCT07239336

Conditions

Celiac Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo DONQ52

Simulated Inadvertent Gluten Exposure (SIGE) capsule

DONQ52

Simulated Inadvertent Gluten Exposure (SIGE) capsule

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-06. This information was provided to ClinicalTrials.gov by Chugai Pharmaceutical on 2026-01-08.